These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 3698053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
    Moore MR, Graham SD, Birch R, Irwin L.
    Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Metastatic prostate carcinoma to the mandible: report of case.
    Mesa ML.
    J Oral Surg; 1977 Feb; 35(2):133-5. PubMed ID: 264506
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum].
    Okumura S, Hasegawa J, Ohhara M, Kawamura N, Abe H, Yui Y, Kanamori S, Yoshida K, Nishimura T, Tomita M.
    Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study.
    Qazi R, Khandekar J.
    Am J Clin Oncol; 1983 Apr; 6(2):203-5. PubMed ID: 6681933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II study of spirogermanium in metastatic prostate cancer.
    Dexeus FH, Logothetis C, Samuels ML, Hossan B.
    Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495
    [No Abstract] [Full Text] [Related]

  • 14. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS, Habig H, Crüsemann D.
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the effectiveness of cisplatin in the treatment of disseminated cancer of the prostate].
    Nogueira March JL, Ojea A, Jamardo D, Díez E, Figueiredo L.
    Arch Esp Urol; 1985 Sep; 38(1):28-34. PubMed ID: 4039554
    [No Abstract] [Full Text] [Related]

  • 16. Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.
    Ravry MJ, Moore MR, Omura GA, Esseese I, Bartolucci A.
    Cancer Treat Rep; 1985 Dec; 69(12):1457-8. PubMed ID: 4075322
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of cyproterone acetate on advanced carcinoma of the prostate.
    Geller J, Vazakas G, Fruchtman B, Newman H, Nakao K, Loh A.
    Surg Gynecol Obstet; 1968 Oct; 127(4):748-58. PubMed ID: 5675191
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.